What is Hepatoid Adenocarcinoma of the Soft Tissues?
Hepatoid adenocarcinoma (HAC) is a rare type of cancer that originates outside the liver but resembles liver cancer in appearance and behaviour. This cancer produces a protein called alpha-fetoprotein (AFP), which can be detected in the blood. HAC most commonly develops in the stomach but can also occur in other organs, such as the lungs, ovaries, pancreas, and colon.
Causes
The exact cause of HAC is unknown, but it is believed to result from genetic alterations that cause healthy cells to behave like liver cells. These genetic changes lead to abnormal cell growth and rapid cancer spread. While the precise causes and risk factors remain unclear, these genetic mutations are thought to play a central role in its development.
Signs and Symptoms
Symptoms of HAC vary depending on the affected organ and are often nonspecific, making early detection difficult. Common symptoms include:
- Abdominal discomfort or pain
- Unexplained weight loss
- Persistent fatigue
- Nausea or vomiting
In many cases, early symptoms are absent. Elevated AFP levels in the blood may indicate the presence of HAC.
Diagnosis
Diagnosing HAC can be challenging because it mimics other tumours. Key diagnostic methods include:
- Blood Tests: Elevated AFP levels can indicate HAC.
- Imaging Tests: While CT and MRI scans can help detect tumours, they are not definitive for HAC.
- Biopsy: A tissue sample analysed under a microscope can confirm the diagnosis. Specific markers, such as AFP and hepatocyte-like proteins, can be identified using specialised tests.
Treatment
Treatment options depend on the cancer’s location and stage:
- Surgery: Tumour removal is the primary treatment for early-stage HAC and can improve survival outcomes.
- Chemotherapy: Used to manage or shrink the tumour in more advanced cases.
- Immunotherapy: Emerging treatments aim to strengthen the immune system to fight cancer, offering potential benefits for some patients.
Advances in Treatment
Research continues to focus on developing more effective therapies for HAC. Advanced techniques, such as patient-derived models and tumour genetic testing, are paving the way for personalised treatment approaches that could improve outcomes for patients with this rare cancer.
You can help us with your donation:
Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways: